ATX vs EYE

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ATX

AMPLIA FPO [ATX]

54MEDIUM

EYE

NOVA EYE FPO [EYE]

57MEDIUM

Score Breakdown

ATX EYE
Technical
51
57
Catalyst
51
53
Sentiment
50
50
Fundamental
76
76
Momentum
50
39
Risk Gate
50
45

Key Metrics

ATX Metric EYE
$71.9MMarket Cap$32.8M
1.4MAvg Volume (20d)269K
+0.0%Short InterestN/A
$0.35052-Week High$0.205
$0.10052-Week Low$0.100
+0.0%Daily Change+0.0%
$0.140Reference Price$0.115
-25.5%ROE-42.4%
-160.9%Profit Margin-21.3%

Active Signals

ATX Signals

●Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (13 quarters)
●Moderate P/S ratio (15.0x)
●Revenue declining (-9%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●EPS estimates revised upward (+10pts)
●Near 52-week low (16% of range)

EYE Signals

●MACD momentum is picking up steam
●Stochastic is stretched into overbought — could need a breather
●Volatility is contracting — like a spring being compressed, breakouts often follow
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.0x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

Ask Scout AI to compare ATX and EYE in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ATX vs IMM →ATX vs MAP →ATX vs PNV →AVE vs AVH →AVE vs CVB →
ATX Full Analysis → EYE Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).